In summary, our study detected known and novel mutations in COL1A1 and COL1A2 in OI patients of southern Chinese origin, revealed genotype-phenotype correlation and diversification, and assessed age-specific treatment response of bisphosphonate therapy. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.